MetLife Inc. [MET] is 3.98% higher this YTD. Is it still time to buy?

MetLife Inc. [NYSE: MET] loss -0.69% on the last trading session, reaching $64.98 price per share at the time. The company report on August 30, 2022 that Meredith Ryan-Reid Named CEO of Versant Health, a MetLife Company.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


MetLife, Inc. (NYSE: MET), announced today that Meredith Ryan-Reid has been named CEO of Versant Health, a managed vision care company and wholly-owned subsidiary of MetLife. The appointment is effective September 1.

“Meredith’s experience in multiple facets of the insurance industry, commitment to talent development, and customer-centric approach position her as the ideal leader for the Versant Health team at this stage of the company’s evolution,” said Ramy Tadros, co-chairman of the Versant Health Board of Directors and regional president, U.S. Business at MetLife. “Versant Health’s customers, members, and vision care providers will benefit from her focus on delivering innovative customer-focused solutions.”.

MetLife Inc. represents 809.70 million in outstanding shares, while the company has a total market value of $53.08 billion with the latest information. MET stock price has been found in the range of $64.49 to $65.73.

If compared to the average trading volume of 4.21M shares, MET reached a trading volume of 3866624 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about MetLife Inc. [MET]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $77.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wolfe Research have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 23, 2022. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on May 24, 2022, representing the official price target for MetLife Inc. stock. Previously, the target price had yet another raise to $74, while Jefferies analysts kept a Buy rating on MET stock.

The Average True Range (ATR) for MetLife Inc. is set at 1.27, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.78. The Price to Book ratio for the last quarter was 1.42, with the Price to Cash per share for the same quarter was set at 25.15. Price to Free Cash Flow for MET in the course of the last twelve months was 3.90.

Trading performance analysis for MET stock

MetLife Inc. [MET] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.05. With this latest performance, MET shares gained by 3.32% in over the last four-week period, additionally plugging by 0.84% over the last 6 months – not to mention a rise of 5.03% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 49.25, with the RSI for the last a single of trading hit 44.19, and the three-weeks RSI is set at 50.82 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 63.45, while it was recorded at 65.88 for the last single week of trading, and 65.24 for the last 200 days.

MetLife Inc. [MET]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +10.97. MetLife Inc.’s Net Margin is presently recorded at +9.41.

Return on Equity for this stock inclined to 9.23, with Return on Assets sitting at 0.84.

MetLife Inc. [MET]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to -0.81%.

An analysis of insider ownership at MetLife Inc. [MET]

There are presently around $38,126 million, or 75.20% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: BLACKROCK INC. with ownership of 62,660,874, which is approximately -10.722% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 57,074,015 shares of the stock with an approximate value of $3.71 billion in MET stocks shares; and DODGE & COX, currently with $3.7 billion in MET stock with ownership of nearly -2.495% of the company’s market capitalization.

Positions in MetLife Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 604 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 29,203,306 shares. Additionally, 517 investors decreased positions by around 43,108,074 shares, while 201 investors held positions by with 514,426,274 shares. The mentioned changes placed institutional holdings at 586,737,654 shares, according to the latest SEC report filing. MET stock had 97 new institutional investments in for a total of 3,616,459 shares, while 115 institutional investors sold positions of 5,233,562 shares during the same period.


Please enter your comment!
Please enter your name here